COMPUGROUP MEDICAL | NEUTRAL | EUR84 Solid Q3 print as data-driven businesses continue to accelerate
COMPUGROUP MEDICAL | NEUTRAL | EUR84Solid Q3 print as data-driven businesses continue to accelerate
Organic growth solid at 7.0% - driven by ambulatory and data businesses
EBITDA beat driven by lower consolidation costs
Guidance reiterated – minor increase in consensus estimates expected
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.